Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-19T02:01:12.773Z Has data issue: false hasContentIssue false

Section 9 - Vasospastic Conditions and Other Miscellaneous Vasculopathies

Published online by Cambridge University Press:  15 June 2018

Edited by
Louis Caplan  and
José Biller
Louis Caplan
Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller
Affiliation:
Loyola University Stritch School of Medicine, Chicago
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Uncommon Causes of Stroke , pp. 597 - 632
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Fisher, CM. Cerebral ischemia: Less familiar types (review). Clin Neurosurg. 1971;18:267–336.Google Scholar
Millikan, CH, editor, Accidents Vasculaires Cerebraux Chez les Femmes Agees de 15 a 45 Ans. Maladies Vasculaires Cerebrales. I Conference de la Salpetriere; 1975; Hospital de la Salpetriere, Paris: J-B Balliere.Google Scholar
Rascol, A, Guiraud, B, Manelfe, C, Clanet, M, editors. Accidents Vasculaires Cerebraux de la Grossesse et du Post Partum. II Conference de la Salpetriere sur les Maladies Vasculaires Cerebrales; 1979; Hospital de la Salpetriere, Paris: J-B Balliere.Google Scholar
Bogousslavsky, J, Despland, PA, Regli, F, Dubuis, PY. Postpartum cerebral angiopathy: Reversible vasoconstriction assessed by transcranial Doppler ultrasounds. Eur Neurol. 1989;29:102–5.Google Scholar
Call, GK, Fleming, MC, Sealfon, S, et al. Reversible cerebral segmental vasoconstriction. Stroke. 1988;19:1159–70.Google Scholar
Noskin, O, Jafarimojarrad, E, Libman, RB, Nelson, JL. Diffuse cerebral vasoconstriction (Call–Fleming syndrome) and stroke associated with antidepressants. Neurology. 2006;67:159–60.Google Scholar
Nowak, DA, Rodiek, SO, Henneken, S, et al. Reversible segmental cerebral vasoconstriction (Call–Fleming syndrome): Are calcium channel inhibitors a potential treatment option? Cephalalgia. 2003;23:218–22.CrossRefGoogle ScholarPubMed
Singhal, AB, Caviness, VS, Begleiter, AF, et al. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology. 2002;58:130–3.Google Scholar
Serdaru, M, Chiras, J, Cujas, M, Lhermitte, F. Isolated benign cerebral vasculitis or migrainous vasospasm? J Neurol Neurosurg Psychiatry. 1984;47:73–6.Google Scholar
Jackson, M, Lennox, G, Jaspan, T, Jefferson, D. Migraine angiitis precipitated by sex headache and leading to watershed infarction. Cephalalgia. 1993;13:427–30.Google Scholar
Day, JW, Raskin, NH. Thunderclap headache: Symptom of unruptured cerebral aneurysm. Lancet. 1986;2:1247–8.Google Scholar
Slivka, A, Philbrook, B. Clinical and angiographic features of thunderclap headache. Headache. 1995;35:1–6.Google Scholar
Dodick, DW, Brown, RD Jr., Britton, JW, Huston, J III. Nonaneurysmal thunderclap headache with diffuse, multifocal, segmental, and reversible vasospasm. Cephalalgia. 1999;19:118–23.Google Scholar
Henry, PY, Larre, P, Aupy, M, Lafforgue, JL, Orgogozo, JM. Reversible cerebral arteriopathy associated with the administration of ergot derivatives. Cephalalgia. 1984;4:171–8.Google Scholar
Raroque, HG Jr., Tesfa, G, Purdy, P. Postpartum cerebral angiopathy. Is there a role for sympathomimetic drugs? Stroke. 1993;24:2108–10.Google Scholar
Razavi, M, Bendixen, B, Maley, JE, et al. CNS pseudovasculitis in a patient with pheochromocytoma. Neurology. 1999;52:1088–90.Google Scholar
Snyder, BD, McClelland, RR. Isolated benign cerebral vasculitis. Arch Neurol. 1978;35:612–4.Google Scholar
Bettoni, L, Juvarra, G, Bortone, E, Lechi, A. Isolated benign cerebral vasculitis. Case report and review. Acta Neurol Belg. 1984;84:161–73.Google ScholarPubMed
van Calenbergh, F, van den Bergh, V, Wilms, G. Benign isolated arteritis of the central nervous system. Clin Neurol Neurosurg. 1986;88:267–73.CrossRefGoogle ScholarPubMed
Calabrese, LH, Gragg, LA, Furlan, AJ. Benign angiopathy: A distinct subset of angiographically defined primary angiitis of the central nervous system. J Rheumatol. 1993;20:2046–50.Google Scholar
Singhal, AB. Cerebral vasoconstriction syndromes. Top Stroke Rehabil. 2004;11:1–6.Google Scholar
Singhal, AB. Cerebral vasoconstriction without subarachnoid blood: Associated conditions, clinical and neuroimaging characteristics. Ann Neurol. 2002:52:S59–60.Google Scholar
Singhal, AB, Koroshetz, WJ, Caplan, LR. Reversible cerebral vasoconstriction syndromes. In Bogousslavsky, J, Caplan, LR, editors. Uncommon Causes of Stroke, 1st edn, 2001. Cambridge: Cambridge University Press;Google Scholar
Hajj-Ali, RA, Furlan, A, Abou-Chebel, A, Calabrese, LH. Benign angiopathy of the central nervous system: Cohort of 16 patients with clinical course and long-term followup. Arthritis Rheum. 2002;47:662–9.Google Scholar
Hajj-Ali, RA, Calabrese, LH. Central nervous system vasculitis. Curr Opin Rheumatol. 2009;21:10–8.Google Scholar
Calabrese, LH, Dodick, DW, Schwedt, TJ, Singhal, AB. Narrative review: Reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007;146:34–44.Google Scholar
Chen, SP, Fuh, JL, Chang, FC, et al. Transcranial color Doppler study for reversible cerebral vasoconstriction syndromes. Ann Neurol. 2008;63:751–7.Google Scholar
Chen, SP, Fuh, JL, Wang, SJ, et al. Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Ann Neurol. 2010;67:648–56.Google Scholar
Ducros, A, Boukobza, M, Porcher, R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091–101.Google Scholar
Ducros, A, Fiedler, U, Porcher, R, et al. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: Frequency, features, and risk factors. Stroke. 2010;41:2505–11.Google Scholar
Fugate, JE, Ameriso, SF, Ortiz, G, et al. Variable presentations of postpartum angiopathy. Stroke. 2012;43:670–6.Google Scholar
Gerretsen, P, Kern, RZ. Reversible cerebral vasoconstriction syndrome or primary angiitis of the central nervous system? Can J Neurol Sci. 2007;34:467–77.Google Scholar
Hajj-Ali, RA, Singhal, AB, Benseler, S, Molloy, E, Calabrese, LH. Primary angiitis of the CNS. Lancet Neurol. 2011;10:561–72.CrossRefGoogle ScholarPubMed
Katz, BS, Fugate, JE, Ameriso, SF, et al. Clinical worsening in reversible cerebral vasoconstriction syndrome. JAMA Neurol. 2014;71:68–73.Google Scholar
Muehlschlegel, S, Kursun, O, Topcuoglu, MA, Fok, J, Singhal, AB. Differentiating reversible cerebral vasoconstriction syndrome with subarachnoid hemorrhage from other causes of subarachnoid hemorrhage. JAMA Neurol. 2013;70:1254–60.Google Scholar
Singhal, AB, Hajj-Ali, RA, Topcuoglu, MA, et al. Reversible cerebral vasoconstriction syndromes: Analysis of 139 cases. Arch Neurol. 2011;68:1005–12.Google Scholar
Chen, SP, Fuh, JL, Lirng, JF, Wang, YF, Wang, SJ. Recurrence of reversible cerebral vasoconstriction syndrome: A long-term follow-up study. Neurology. 2015;84:1552–8.CrossRefGoogle ScholarPubMed
John, S, Singhal, AB, Calabrese, L, et al. Long-term outcomes after reversible cerebral vasoconstriction syndrome. Cephalalgia. 2016;36:387–94.Google Scholar
Singhal, AB, Topcuoglu, MA, Fok, JW, et al. Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: Clinical, imaging, and angiographic comparison. Ann Neurol. 2016;79:882–94.Google Scholar
Singhal, AB, Topcuoglu, MA. Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology. 2017; 88:228–36.CrossRefGoogle ScholarPubMed
Topcuoglu, MA, Kursun, O, Singhal, AB. Coexisting vascular lesions in reversible cerebral vasoconstriction syndrome. Cephalalgia. 2017;37:29–35.Google Scholar
Topcuoglu, MA, Chan, ST, Silva, GS, et al. Cerebral vasomotor reactivity in reversible cerebral vasoconstriction syndrome. Cephalalgia. 2017;37:541–7.Google Scholar
Chen, SP, Yang, AC, Fuh, JL, Wang, SJ. Autonomic dysfunction in reversible cerebral vasoconstriction syndromes. J Headache Pain. 2013;14:94.Google Scholar
Chen, SP, Fuh, JL, Wang, SJ, et al. Brain-derived neurotrophic factor gene Val66 Met polymorphism modulates reversible cerebral vasoconstriction syndromes. PLoS One. 2011;6:e18024.CrossRefGoogle Scholar
Chen, SP, Chung, YT, Liu, TY, et al. Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome. Free Radic Biol Med. 2013;61:243–8.Google Scholar
Bartynski, WS. Posterior reversible encephalopathy syndrome, part 1: Fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036–42.Google Scholar
Chen, SP, Fuh, JL, Lirng, JF, Chang, FC, Wang, SJ. Recurrent primary thunderclap headache and benign CNS angiopathy: Spectra of the same disorder? Neurology. 2006;67:2164–9.Google Scholar
Chen, SP, Wang, YF, Huang, PH, et al. Reduced circulating endothelial progenitor cells in reversible cerebral vasoconstriction syndrome. J Headache Pain. 2014;15:82.Google Scholar
Topcuoglu, MA, McKee, KE, Singhal, AB. Gender and hormonal influences in reversible cerebral vasoconstriction syndrome. Eur Stroke J. 2016;1:199–204.Google Scholar
Kirton, A, Diggle, J, Hu, W, Wirrell, E. A pediatric case of reversible segmental cerebral vasoconstriction. Can J Neurol Sci. 2006;33:250–3.Google Scholar
Liu, HY, Fuh, JL, Lirng, JF, Chen, SP, Wang, SJ. Three paediatric patients with reversible cerebral vasoconstriction syndromes. Cephalalgia. 2010;30:354–9.CrossRefGoogle ScholarPubMed
Yoshioka, S, Takano, T, Ryujin, F, Takeuchi, Y. A pediatric case of reversible cerebral vasoconstriction syndrome with cortical subarachnoid hemorrhage. Brain Dev. 2012;34:796–8.Google Scholar
Meschia, JF, Malkoff, MD, Biller, J. Reversible segmental cerebral arterial vasospasm and cerebral infarction: Possible association with excessive use of sumatriptan and Midrin. Arch Neurol. 1998;55:712–4.Google Scholar
Dietrich, HH, Dacey, RG Jr. Molecular keys to the problems of cerebral vasospasm. Neurosurgery. 2000;46:517–30.Google Scholar
Singhal, AB, Kimberly, WT, Schaefer, PW, Hedley-Whyte, ET. Case records of the Massachusetts General Hospital. Case 8–2009. A 36-year-old woman with headache, hypertension, and seizure 2 weeks post partum. N Engl J Med. 2009;360:1126–37.Google Scholar
Buckle, RM, Du Boulay, G, Smith, B. Death due to cerebral vasospasm. J Neurol Neurosurg Psychiatry. 1964;27:440–4.Google Scholar
Williams, TL, Lukovits, TG, Harris, BT, Harker Rhodes, C. A fatal case of postpartum cerebral angiopathy with literature review. Arch Gynecol Obstet. 2007;275:67–77.Google Scholar
Fugate, JE, Wijdicks, EF, Parisi, JE, et al. Fulminant postpartum cerebral vasoconstriction syndrome. Arch Neurol. 2012;69:111–7.Google Scholar
Armstrong, FS, Hayes, GJ. Segmental cerebral arterial constriction associated with pheochromocytoma. J Neurosurg. 1961;18:843–6.Google Scholar
Topcuoglu, MA, Jha, RM, George, J, Frosch, MP, Singhal, AB. Hemorrhagic primary CNS angiitis from vasoconstrictive agents. Neurol Clin Pract. 2017;7:26–34.Google Scholar
Calado, S, Vale-Santos, J, Lima, C, Viana-Baptista, M. Postpartum cerebral angiopathy: Vasospasm, vasculitis or both? Cerebrovasc Dis. 2004;18:340–1.Google Scholar
Schwedt, TJ, Matharu, MS, Dodick, DW. Thunderclap headache. Lancet Neurol. 2006;5:621–31.Google Scholar
Topcuoglu, MA, Singhal, AB. Hemorrhagic reversible cerebral vasoconstriction syndrome: Features and mechanisms. Stroke. 2016;47:1742–7.CrossRefGoogle ScholarPubMed
Edlow, BL, Kasner, SE, Hurst, RW, Weigele, JB, Levine, JM. Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage. Neurocrit Care. 2007;7:203–10.Google Scholar
Moustafa, RR, Allen, CM, Baron, JC. Call–Fleming syndrome associated with subarachnoid haemorrhage: Three new cases. J Neurol Neurosurg Psychiatry. 2008;79:602–5.Google Scholar
Singhal, AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol. 2004;61:411–6.Google Scholar
Kumar, S, Goddeau, RP Jr., Selim, MH, et al. Atraumatic convexal subarachnoid hemorrhage: Clinical presentation, imaging patterns, and etiologies. Neurology. 2010;74:893–9.Google Scholar
Rico, M, Benavente, L, Para, M, et al. Headache as a crucial symptom in the etiology of convexal subarachnoid hemorrhage. Headache. 2014;54:545–50.Google Scholar
Mathon, B, Ducros, A, Bresson, D, et al. Subarachnoid and intra-cerebral hemorrhage in young adults: Rare and underdiagnosed. Rev Neurol (Paris). 2014;170:110–8.Google Scholar
Chen, SP, Fuh, JL, Lirng, JF, Wang, SJ. Hyperintense vessels on FLAIR imaging in reversible cerebral vasoconstriction syndrome. Cephalalgia. 2012;32:271–8.Google Scholar
Iancu-Gontard, D, Oppenheim, C, Touze, E, et al. Evaluation of hyperintense vessels on FLAIR MRI for the diagnosis of multiple intracerebral arterial stenoses. Stroke. 2003;34:1886–91.Google Scholar
Santos, E, Zhang, Y, Wilkins, A, Renowden, S, Scolding, N. Reversible cerebral vasoconstriction syndrome presenting with haemorrhage. J Neurol Sci. 2009;276:189–92.Google Scholar
Bartynski, WS, Boardman, JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2008;29:447–55.Google Scholar
Rothrock, JF, Walicke, P, Swenson, MR, Lyden, PD, Logan, WR. Migrainous stroke. Arch Neurol. 1988;45:63–7.Google Scholar
Mawet, J, Boukobza, M, Franc, J, Sarov, M, Arnold, M, Bousser, MG, et al. Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients. Neurology. 2013;81:821–4.Google Scholar
Nighoghossian, N, Derex, L, Trouillas, P. Multiple intracerebral hemorrhages and vasospasm following antimigrainous drug abuse. Headache. 1998;38:478–80.Google Scholar
Singhal, AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol. 2004;61:411–6.Google Scholar
Muehlschlegel, S, Rordorf, G, Bodock, M, Sims, JR. Dantrolene mediates vasorelaxation in cerebral vasoconstriction: A case series. Neurocrit Care. 2009;10:116–21.Google Scholar
Ringer, AJ, Qureshi, AI, Kim, SH, et al. Angioplasty for cerebral vasospasm from eclampsia. Surg Neurol. 2001;56:373–8.Google Scholar
Song, JK, Fisher, S, Seifert, TD, et al. Postpartum cerebral angiopathy: Atypical features and treatment with intracranial balloon angioplasty. Neuroradiology. 2004;46:1022–6.Google Scholar
Bouchard, M, Verreault, S, Gariepy, JL, Dupre, N. Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome. Headache. 2009;49:142–5.Google Scholar
Linn, J, Fesl, G, Ottomeyer, C, et al. Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: A diagnostic tool in select cases? Cephalalgia. 2011;31:1074-81.Google Scholar
Singhal, AB. Diagnostic challenges in RCVS, PACNS, and other cerebral arteriopathies. Cephalalgia. 2011;31:1067–70.Google Scholar
Ursell, MR, Marras, CL, Farb, R, et al. Recurrent intracranial hemorrhage due to postpartum cerebral angiopathy: Implications for management. Stroke. 1998;29:1995–8.Google Scholar

References

Kuklina, EV, Tong, X, Bansil, P, George, MG, Callaghan, WM. Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: Reasons for concern? Stroke. 2011;42:2564–70.Google Scholar
Lidegaard, O, Lokkegaard, E, Jensen, A, Skovlund, CW, Keiding, N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366:2257–66.Google Scholar
Kittner, SJ, Stern, BJ, Feeser, BR, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335:768–74.Google Scholar
Bateman, BT, Schumacher, HC, Bushnell, CD, et al. Intracerebral hemorrhage in pregnancy: Frequency, risk factors, and outcome. Neurology. 2006;67:424–9.Google Scholar
Scott, CA, Bewley, S, Rudd, A, et al. Incidence, risk factors, management, and outcomes of stroke in pregnancy. Obstet Gynecol. 2012;120: 318–24.Google Scholar
Kamel, H, Navi, BB, Sriram, N, et al. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370:1307–15.Google Scholar
O’Donnell, MJ, Xavier, D, Liu, L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case–control study. Lancet. 2010;376:112–23.Google Scholar
Liang, CC, Chang, SD, Lai, SL, et al. Stroke complicating pregnancy and the puerperium. Eur J Neurol. 2006;13:1256–60.Google Scholar
Tang, CH, Wu, CS, Lee, TH, et al. Preeclampsia–eclampsia and the risk of stroke among peripartum in Taiwan. Stroke. 2009;40:1162–8.Google Scholar
Sharshar, T, Lamy, C, Mas, JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke. 1995;26:930–6.Google Scholar
Bateman, BT, Olbrecht, VA, Berman, MF, et al. Peripartum subarachnoid hemorrhage: Nationwide data and institutional experience. Anesthesiology. 2012;116:324–33.Google Scholar
Kim, YW, Neal, D, Hoh, BL. Cerebral aneurysms in pregnancy and delivery: Pregnancy and delivery do not increase the risk of aneurysm rupture. Neurosurgery. 2013;72:143–9.Google Scholar
Leffert, LR, Clancy, CR, Bateman, BT, et al. Treatment patterns and short-term outcomes in ischemic stroke in pregnancy or postpartum period. Am J Obstet Gynecol. 2016;214:723.Google Scholar
Leffert, LR, Clancy, CR, Bateman, BT, et al. Patient characteristics and outcomes after hemorrhagic stroke in pregnancy. Circ Cardiovasc Qual Outcomes. 2015;8:S170–178.CrossRefGoogle ScholarPubMed
Cruz-Herranz, A, Illan-Gala, I, Martinez-Sanchez, P, Fuentes, B, Diez-Tejedor, E. Recurrence of stroke amongst women of reproductive age: Impact of and on subsequent pregnancies. Eur J Neurol. 2015;22:681-e642.Google Scholar
American College of Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–31.Google Scholar
Sibai, BM. Eclampsia. In Goldstein, PJ, Stern, BJ, eds. Neurological Disorders of Pregnancy. Mount Kisco, NY: Futura Publishing; 1992, pp. 1–24.Google Scholar
Douglas, KA, Redman, CW. Eclampsia in the United Kingdom. BMJ. 1994;309:1395–400.Google Scholar
Hirshfeld-Cytron, J, Lam, C, Karumanchi, SA, Lindheimer, M. Late postpartum eclampsia: Examples and review. Obstet Gynecol Surv. 2006;61:471–80.Google Scholar
Andersgaard, AB, Herbst, A, Johansen, M, et al. Eclampsia in Scandinavia: Incidence, substandard care, and potentially preventable cases. Acta Obstet Gynecol Scand. 2006;85:929–36.Google Scholar
Lopez-Jaramillo, P, Garcia, RG, Lopez, M. Preventing pregnancy-induced hypertension: Are there regional differences for this global problem? J Hypertens. 2005;23:1121–9.Google Scholar
Creanga, AA, Berg, CJ, Syverson, C, Seed, K, Bruce, FC, Callaghan, WM. Pregnancy-related mortality in the United States, 2006–2010. Obstet Gynecol. 2015;125:5–12.Google Scholar
Duckitt, K, Harrington, D. Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ. 2005;330:565.Google Scholar
Foo, L, Bewley, S, Rudd, A. Maternal death from stroke: A thirty year national retrospective review. Eur J Obstet Gynecol Reprod Biol. 2013;171:266–70.Google Scholar
MacKay, AP, Berg, CJ, Atrash, HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001;97:533–8.Google ScholarPubMed
Lucas, MJ, Leveno, KJ, Cunningham, FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333:201–5.Google Scholar
Anon. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345:1455–63.Google Scholar
Belfort, MA, Anthony, J, Saade, GR, Allen, JC Jr., Nimodipine Study, Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med. 2003;348:304–11.Google Scholar
Altman, D, Carroli, G, Duley, L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. Lancet. 2002;359:1877–90.Google Scholar
Duley, L, Henderson-Smart, DJ, Meher, S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2006:CD001449.Google Scholar
Granger, JP, Alexander, BT, Llinas, MT, Bennett, WA, Khalil, RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension. 2001; 38: 718–22.Google Scholar
Khong, TY, De Wolf, F, Robertson, WB, Brosens, I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93:1049–59.Google Scholar
Johnson, AC, Cipolla, MJ. The cerebral circulation during pregnancy: Adapting to preserve normalcy. Physiology (Bethesda). 2015;30:139–47.Google Scholar
Wilson, ML, Goodwin, TM, Pan, VL, Ingles, SA. Molecular epidemiology of preeclampsia. Obstet Gynecol Surv. 2003;58:39–66.Google Scholar
Esplin, MS, Fausett, MB, Fraser, A, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med. 2001;344:867–72.Google Scholar
Easton, JD. Severe preeclampsia/eclampsia: Hypertensive encephalopathy of pregnancy? Cerebrovasc Dis. 1998;8:53–8.Google Scholar
Schobel, HP, Fischer, T, Heuszer, K, Geiger, H, Schmieder, RE. Preeclampsia: A state of sympathetic overactivity. N Engl J Med. 1996;335:1480–5.Google Scholar
Witlin, AG, Friedman, SA, Egerman, RS, Frangieh, AY, Sibai, BM. Cerebrovascular disorders complicating pregnancy: Beyond eclampsia. Am J Obstet Gynecol. 1997;176:1139–1145.CrossRefGoogle ScholarPubMed
Singhal, AB, Hajj-Ali, RA, Topcuoglu, MA, et al. Reversible cerebral vasoconstriction syndromes: Analysis of 139 cases. Arch Neurol. 2011;68:1005–12.CrossRefGoogle ScholarPubMed
Singhal, AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol. 2004;61:411–16.Google Scholar
Tanaka, K, Matsushima, M, Matsuzawa, Y, et al. Antepartum reversible cerebral vasoconstriction syndrome with pre-eclampsia and reversible posterior leukoencephalopathy. J Obstet Gynaecol Res. 2015;41:1843–7.Google Scholar
Hinchey, J, Chaves, C, Appignani, B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.Google Scholar
Manfredi, M, Beltramello, A, Bongiovanni, LG, Polo, A, Pistoia, L, Rizzuto, N. Eclamptic encephalopathy: Imaging and pathogenetic considerations. Acta Neurol Scand. 1997;96:277–82.Google Scholar
Demirtas, O, Gelal, F, Vidinli, BD, Demirtas, LO, Uluc, E, Baloglu, A. Cranial MR imaging with clinical correlation in preeclampsia and eclampsia. Diagn Interv Radiol. 2005;11:189–94.Google Scholar
Bartynski, WS. Posterior reversible encephalopathy syndrome, part 1: Fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29(6):1036–42.Google Scholar
Hefzy, HM, Bartynski, WS, Boardman, JF, Lacomis, D. Hemorrhage in posterior reversible encephalopathy syndrome: Imaging and clinical features. AJNR Am J Neuroradiol. 2009;30:1371–9.Google Scholar
Pande, AR, Ando, K, Ishikura, R, et al. Clinicoradiological factors influencing the reversibility of posterior reversible encephalopathy syndrome: A multicenter study. Radiat Med. 2006;24:659–68.Google Scholar
Akins, PT, Axelrod, Y, Silverthorn, JW, et al. Management and outcomes of malignant posterior reversible encephalopathy syndrome. Clin Neurol Neurosurg. 2014;125:52–7.Google Scholar
Bartynski, WS. Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043–9.Google Scholar
Demir, BC, Ozerkan, K, Ozbek, SE, Yildirim Eryilmaz, N, Ocakoglu, G. Comparison of magnesium sulfate and mannitol in treatment of eclamptic women with posterior reversible encephalopathy syndrome. Arch Gynecol Obstet. 2012;286:287–93.Google Scholar
Lanska, DJ, Kryscio, RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke. 2000;31:1274–82.Google Scholar
Coutinho, JM, Ferro, JM, Canhao, P, et al. Cerebral venous and sinus thrombosis in women. Stroke. 2009;40:2356–61.Google Scholar
Nasr, DM, Brinjikji, W, Cloft, HJ, Saposnik, G, Rabinstein, AA. Mortality in cerebral venous thrombosis: Results from the national inpatient sample database. Cerebrovasc Dis. 2013;35:40–4.Google Scholar
Cantu, C, Barinagarrementeria, F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke. 1993;24:1880–4.Google Scholar
Saposnik, G, Barinagarrementeria, F, Brown, RD Jr., et al. Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158–92.CrossRefGoogle ScholarPubMed
Aguiar de Sousa, D, Canhao, P, Ferro, JM. Safety of pregnancy after cerebral venous thrombosis: A systematic review. Stroke. 2016;47:713–18.Google Scholar
Lewey, J, Haythe, J. Cardiomyopathy in pregnancy. Semin Perinatol. 2014;38:309–17.Google Scholar
Sliwa, K, Hilfiker-Kleiner, D, Petrie, MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.Google Scholar
Elkayam, U. Clinical characteristics of peripartum cardiomyopathy in the United States: Diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58:659–70.Google Scholar
Goland, S, Modi, K, Bitar, F, et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009;15:645–50.Google Scholar
Sliwa, K, Blauwet, L, Tibazarwa, K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof-of-concept pilot study. Circulation. 2010;121:1465–73.Google Scholar
Ishii, A, Miyamoto, S. Endovascular treatment in pregnancy. Neurol Med Chir (Tokyo). 2013;53:541–8.Google Scholar
Protection ICoR. Pregnancy and medical radiation. ICRP Publication 84. 2000;30.Google Scholar
Patel, SJ, Reede, DL, Katz, DS, Subramaniam, R, Amorosa, JK. Imaging the pregnant patient for nonobstetric conditions: Algorithms and radiation dose considerations. Radiographics. 2007;27:1705–22.Google Scholar
American College of Radiology and American Society of Neuroradiology Statement on CT Protocols and Radiation Dose. 2009; http://www.acr.org/about-us/media-center/position-statements/position-statements-folder/the-acr-and-american-society-of-neuroradiology-statement-on-ct-protocols-and-radiation-dose. Accessed 1/7/16.Google Scholar
Kozan, A, Yildirmak, ST, Mihmanli, V, et al. Serum oxidized low density lipoprotein levels in preeclamptic and normotensive pregnants. Clin Exp Obstet Gynecol. 2015;42:746–8.Google Scholar
Abbassi-Ghanavati, M, Greer, LG, Cunningham, FG. Pregnancy and laboratory studies: A reference table for clinicians. Obstet Gynecol. 2009;114:1326–31.Google Scholar
Jauch, EC, Saver, JL, Adams, HP Jr., et al. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.Google Scholar
Selim, MH, Molina, CA. The use of tissue plasminogen-activator in pregnancy: A taboo treatment or a time to think out of the box. Stroke. 2013;44:868–9.Google Scholar
Ahearn, GS, Hadjiliadis, D, Govert, JA, Tapson, VF. Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: A case report and review of treatment options. Arch Intern Med. 2002;162:1221–7.Google Scholar
Turrentine, MA, Braems, G, Ramirez, MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv. 1995;50:534–41.Google Scholar
Dapprich, M, Boessenecker, W. Fibrinolysis with alteplase in a pregnant woman with stroke. Cerebrovasc Dis. 2002;13:290.CrossRefGoogle Scholar
Del Zotto, E, Giossi, A, Volonghi, I, Costa, P, Padovani, A, Pezzini, A. Ischemic stroke during pregnancy and puerperium. Stroke Res Treat. 2011;2011:606780.Google Scholar
Li, Y, Margraf, J, Kluck, B, Jenny, D, Castaldo, J. Thrombolytic therapy for ischemic stroke secondary to paradoxical embolism in pregnancy: A case report and literature review. Neurologist. 2012;18:44–8.Google Scholar
Ritchie, J, Lokman, M, Panikkar, J. Thrombolysis for stroke in pregnancy at 39 weeks gestation with a subsequent normal delivery. BMJ Case Rep. 2015 ;2015:bcr2015209563.Google Scholar
Demchuk, AM. Yes, intravenous thrombolysis should be administered in pregnancy when other clinical and imaging factors are favorable. Stroke. 2013;44:864–5.Google Scholar
Broderick, JP. Should intravenous thrombolysis be considered the first option in pregnant women? Stroke. 2013;44:866–7.Google Scholar
Demaerschalk, BM, Kleindorfer, DO, Adeoye, OM, et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47:581–641.Google Scholar
Powers, WJ, Derdeyn, CP, Biller, J, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:3020–35.Google Scholar
Abou-Chebl, A, Lin, R, Hussain, MS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: Preliminary results from a retrospective, multicenter study. Stroke. 2010;41:1175–9.Google Scholar
Bushnell, C, McCullough, LD, Awad, IA, et al. Guidelines for the prevention of stroke in women: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1545–88.Google Scholar
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy. Obstet Gynecol. 2012; 119:396–407.Google Scholar
Abalos, E, Duley, L, Steyn, DW, Henderson-Smart, DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2007:CD002252.Google Scholar
von Dadelszen, P, Magee, LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: An updated metaregression analysis. J Obstet Gynaecol Can. 2002;24:941–5.Google Scholar
Brown, DW, Dueker, N, Jamieson, DJ, et al. Preeclampsia and the risk of ischemic stroke among young women: Results from the Stroke Prevention in Young Women study. Stroke. 2006;37:1055–9.Google Scholar
Irgens, HU, Reisaeter, L, Irgens, LM, Lie, RT. Long term mortality of mothers and fathers after pre-eclampsia: Population based cohort study. BMJ. 2001;323:1213–17.Google Scholar
Sattar, N, Greer, IA. Pregnancy complications and maternal cardiovascular risk: Opportunities for intervention and screening? BMJ. 2002;325:157–60.Google Scholar
Wilson, BJ, Watson, MS, Prescott, GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: Results from cohort study. BMJ. 2003;326:845.Google Scholar
Lee, G, Tubby, J. Preeclampsia and the risk of cardiovascular disease later in life: A review of the evidence. Midwifery. 2015;31:1127–34.Google Scholar
Seely, EW, Tsigas, E, Rich-Edwards, JW. Preeclampsia and future cardiovascular disease in women: How good are the data and how can we manage our patients? Semin Perinatol. 2015;39:276–83.Google Scholar
Rich-Edwards, JW, Klungsoyr, K, Wilcox, AJ, Skjaerven, R. Duration of pregnancy, even at term, predicts long-term risk of coronary heart disease and stroke mortality in women: A population-based study. Am J Obstet Gynecol. 2015;213:518e511–18.Google Scholar
Smith, GN, Pudwell, J, Walker, M, Wen, SW. Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can. 2012;34:830–5.Google Scholar
Bellamy, L, Casas, JP, Hingorani, AD, Williams, DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ. 2007;335:974.Google Scholar
McDonald, SD, Malinowski, A, Zhou, Q, Yusuf, S, Devereaux, PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156:918–30.Google Scholar
Aukes, AM, De Groot, JC, Wiegman, MJ, et al. Long-term cerebral imaging after pre-eclampsia. BJOG. 2012;119:1117–22.Google Scholar
Williams, D. Pregnancy: A stress test for life. Curr Opin Obstet Gynecol. 2003;15:465–71.Google Scholar
Romundstad, PR, Magnussen, EB, Smith, GD, Vatten, LJ. Hypertension in pregnancy and later cardiovascular risk: Common antecedents? Circulation. 2010;122:579–84.Google Scholar
Berks, D, Hoedjes, M, Raat, H, et al. Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: A literature-based study. BJOG. 2013;120:924–31.CrossRefGoogle Scholar
Berks, D, Steegers, EA, Molas, M, Visser, W. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol. 2009;114:1307–14.Google Scholar
Amaral, LM, Cunningham, MW Jr., Cornelius, DC, LaMarca, B. Preeclampsia: Long-term consequences for vascular health. Vasc Health Risk Manag. 2015;11:403–15.Google Scholar
Mosca, L, Benjamin, EJ, Berra, K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: A guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404–23.Google Scholar
Heidema, WM, Scholten, RR, Lotgering, FK, Spaanderman, ME. History of preeclampsia is more predictive of cardiometabolic and cardiovascular risk factors than obesity. Eur J Obstet Gynecol Reprod Biol. 2015;194:189–93.Google Scholar
Skurnik, G, Roche, AT, Stuart, JJ, et al. Improving the postpartum care of women with a recent history of preeclampsia: A focus group study. Hypertens Pregnancy. 2016;35:371–81.Google Scholar

References

Agostoni, E., Rigamonti, A., 2012. Migraine and small vessel diseases. Neurol Sci. 33, S51–4.Google Scholar
Amin, F. M., et al., 2013. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: A cross-sectional study. Lancet Neurol. 12, 454–61.Google Scholar
Armstrong, A.E., Gillan, E., DiMario, F.J. Jr., 2014. SMART syndrome (stroke-like migraine attacks after radiation therapy) in adult and pediatric patients. J Child Neurol. 29, 336–41.Google Scholar
Attwell, D., et al., 2010. Glial and neuronal control of brain blood flow. Nature. 468, 232–43.Google Scholar
Bartleson, J.D., Swanson, J.W., Whisnant, J.P., 1981. A migrainous syndrome with cerebrospinal fluid pleocytosis. Neurology. 31, 1257–62.Google Scholar
Bashir, A., et al., 2013. Migraine and structural changes in the brain: A systematic review and meta-analysis. Neurology. 81, 1260–8.Google Scholar
Black, D.F., et al., 2006. SMART: Stroke-like migraine attacks after radiation therapy. Cephalalgia. 26, 1137–42.Google Scholar
Bradshaw, J., et al., 2011. Neurocognitive recovery in SMART syndrome: A case report. Cephalalgia. 31, 372–6.Google Scholar
Burke, M. J., et al., 2017. Unique CT perfusion imaging in a case of HaNDL: New insight into HaNDL pathophysiology and vasomotor principles of cortical spreading depression. Headache. 57, 129–34.Google Scholar
Caputi, L., et al., 2010. Microembolic air load during contrast-transcranial Doppler: A trigger for migraine with aura? Headache. 50, 1320–7.Google Scholar
Cavazos, J.E., et al., 1994. Sumatriptan-induced stroke in sagittal sinus thrombosis. Lancet. 343, 1105–6.Google Scholar
Chabriat, H., et al., 2009. CADASIL. Lancet Neurol. 8, 643–53.Google Scholar
Chang, C.L., Donaghy, M., Poulter, N., 1999. Migraine and stroke in young women: Case–control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ. 318, 13–8.Google Scholar
Davis, D., et al., 2013. Patent foramen ovale, ischemic stroke and migraine: Systematic review and stratified meta-analysis of association studies. Neuroepidemiology. 40, 56–67.Google Scholar
Debette, S., 2015. Comment: Tackling shared genetic underpinnings of migraine and ischemic stroke. Neurology. 84, 2143.Google Scholar
Dowson, A., et al., 2008. Migraine Intervention with StarFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with StarFlex septal repair implant to resolve refractory migraine headache. Circulation. 117, 1397–404.Google Scholar
Dreier, J. P., 2011. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 17, 439–47.Google Scholar
Eising, E., et al., 2013. Pearls and pitfalls in genetic studies of migraine. Cephalalgia. 33, 614–25.Google Scholar
Emond, H., et al., 2009. Syndrome of transient headache and neurological deficits with CSF lymphocytosis (HaNDL) associated with recent human herpes virus-6 infection. Cephalalgia. 29, 487–91.Google Scholar
Etminan, M., et al., 2005. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ. 330, 63.Google Scholar
Friedenberg, S., Dodick, D. W., 2000. Migraine-associated seizure: A case of reversible MRI abnormalities and persistent nondominant hemisphere syndrome. Headache. 40, 487–90.Google Scholar
Fuentes, B., Diez-Tejedor, E., Frank, A., 1998. Syndrome of headache with neurological deficits and CSF lymphocytosis: A spreading depression mechanism? The role of SPECT. Headache. 38, 324.Google Scholar
Galimi, R., 2012. Migraine and ischemic stroke: Possible pathogenic relation. Recenti Prog Med. 103, 319–27.Google Scholar
Gomez-Aranda, F., et al., 1997. Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. Brain. 120, 1105–13.Google Scholar
Gormley, P., et al., 2016. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 48, 856–66.Google Scholar
Guillon, B., et al., 2007. Do extracellular-matrix-regulating enzymes play a role in cervical artery dissection? Cerebrovasc Dis. 23, 299–303.Google Scholar
Gursoy-Ozdemir, Y., et al., 2004. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 113, 1447–55.Google Scholar
Hadjikhani, N., et al., 2001. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA. 98, 4687–92.Google Scholar
Hall, G.C., et al., 2004. Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice. Neurology. 62, 563–8.Google Scholar
Hamedani, A.G., et al., 2013. Migraine and white matter hyperintensities: The ARIC MRI study. Neurology. 81, 1308–13.Google Scholar
Kaderali, Z., Lamberti-Pasculli, M., Rutka, J.T., 2009. The changing epidemiology of paediatric brain tumours: A review from the Hospital for Sick Children. Childs Nerv Syst. 25, 787–93.Google Scholar
Kappler, J., Mohr, S., Steinmetz, H., 1997. Cerebral vasomotor changes in the transient syndrome of headache with neurologic deficits and CSF lymphocytosis (HaNDL). Headache. 37, 516–8.Google Scholar
Kerklaan, J.P., et al., 2011. SMART syndrome: A late reversible complication after radiation therapy for brain tumours. J Neurol. 258, 1098–104.Google Scholar
Kowa, H., et al., 2005. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett. 374, 129–31.Google Scholar
Kruit, M. C., et al., 2004. Migraine as a risk factor for subclinical brain lesions. JAMA. 291, 427–34.Google Scholar
Kruit, M. C., et al., 2005. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain. 128, 2068–77.Google Scholar
Kruit, M. C., et al., 2006. Brain stem and cerebellar hyperintense lesions in migraine. Stroke. 37, 1109–12.Google Scholar
Kurth, T., Tzourio, C., 2009. Migraine and cerebral infarct-like lesions on MRI: An observation, not a disease. JAMA. 301, 2594–5.Google Scholar
Kurth, T., Diener, H.C., 2012. Migraine and stroke: Perspectives for stroke physicians. Stroke. 43, 3421–6.Google Scholar
Kurth, T., et al., 2009. Migraine frequency and risk of cardiovascular disease in women. Neurology. 73, 581–8.Google Scholar
Kurth, T., et al., 2010. Migraine and risk of haemorrhagic stroke in women: Prospective cohort study. BMJ. 341, c3659.Google Scholar
Kurth, T., et al., 2016. Migraine and risk of cardiovascular disease in women: Prospective cohort study. BMJ. 353, i2610.Google Scholar
Kurtuncu, M., et al., 2013. CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL). Cephalalgia. 33, 123–9.Google Scholar
Larrosa-Campo, D., et al., 2012. Migraine as a vascular risk factor. Rev Neurol. 55, 349–58.Google Scholar
Laurell, K., et al., 2011. Migrainous infarction: A Nordic multicenter study. Eur J Neurol. 18, 1220–6.Google Scholar
Laurell, K., Lundstrom, E., 2012. Migrainous infarction: Aspects on risk factors and therapy. Curr Pain Headache Rep. 16, 255–60.Google Scholar
Lauritzen, M., 1994. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 117, 199–210.Google Scholar
Lee, M.J., Lee, C., Chung, C.S., 2016. The migraine–stroke connection. J Stroke. 18, 146–56.Google Scholar
Leira, R., et al., 2007. MMP-9 immunoreactivity in acute migraine. Headache. 47, 698–702.Google Scholar
MacClellan, L.R., et al., 2007. Probable migraine with visual aura and risk of ischemic stroke: The Stroke Prevention in Young Women study. Stroke. 38, 2438–45.Google Scholar
Malik, R., et al., 2015. Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants. Neurology. 84, 2132–45.Google Scholar
Martin-Balbuena, S., Arpa-Gutierrez, F.J., 2007. Pseudomigraine with cerebrospinal fluid pleocytosis or syndrome of headache, temporary neurological deficit and cerebrospinal fluid. A historical review. Rev Neurol. 45, 624–30.Google Scholar
Mawet, J., Kurth, T., Ayata, C., 2015. Migraine and stroke: In search of shared mechanisms. Cephalalgia. 35, 165–81.Google Scholar
Meschia, J.F., et al., 2014. Guidelines for the primary prevention of stroke: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 45, 3754–832.Google Scholar
Metso, T.M., et al., 2012. Migraine in cervical artery dissection and ischemic stroke patients. Neurology. 78, 1221–8.Google Scholar
Olesen, J., et al., 1993. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain. 116, 187–202.Google Scholar
Paemeleire, K., 2009. Brain lesions and cerebral functional impairment in migraine patients. J Neurol Sci. 283, 134–6.Google Scholar
Palm-Meinders, I.H., et al., 2012. Structural brain changes in migraine. JAMA. 308, 1889–97.Google Scholar
Partap, S., et al., 2006. Prolonged but reversible migraine-like episodes long after cranial irradiation. Neurology. 66, 1105–7.Google Scholar
Paterna, S., et al., 2000. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol. 43, 133–6.Google Scholar
Pettersen, J.A., et al., 2008. Global hemispheric CT hypoperfusion may differentiate headache with associated neurological deficits and lymphocytosis from acute stroke. Stroke. 39, 492–3.Google Scholar
Pezzini, A., et al., 2007. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke. 38, 3145–51.Google Scholar
Pezzini, A., et al., 2011. Predictors of migraine subtypes in young adults with ischemic stroke: The Italian project on stroke in young adults. Stroke. 42, 17–21.Google Scholar
Piilgaard, H., Lauritzen, M., 2009. Persistent increase in oxygen consumption and impaired neurovascular coupling after spreading depression in rat neocortex. J Cereb Blood Flow Metab. 29, 1517–27.Google Scholar
Pruitt, A., et al., 2006. Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology. 67, 676–8.Google Scholar
Rigatelli, G., et al., 2011. May migraine post-patent foramen ovale closure sustain the microembolic genesis of cortical spread depression? Cardiovasc Revasc Med. 12, 217–9.Google Scholar
Ripa, P., et al., 2015. Spreading depolarization may link migraine, stroke, and other cardiovascular disease. Headache. 55, 180–2.Google Scholar
Rist, P.M., et al., 2011. Migraine, migraine aura, and cervical artery dissection: A systematic review and meta-analysis. Cephalalgia. 31, 886–96.Google Scholar
Sacco, S., et al., 2013. Migraine and hemorrhagic stroke: A meta-analysis. Stroke. 44, 3032–8.Google Scholar
Santos, E., et al., 2012. Spreading depolarizations in a case of migraine-related stroke. Cephalalgia. 32, 433–6.Google Scholar
Scher, A.I., et al., 2009. Migraine headache in middle age and late-life brain infarcts. JAMA. 301, 2563–70.Google Scholar
Schurks, M., et al., 2008. Interrelationships among the MTHFR 677 C>T polymorphism, migraine, and cardiovascular disease. Neurology. 71, 505–13.Google Scholar
Schurks, M., et al., 2009. Migraine and cardiovascular disease: Systematic review and meta-analysis. BMJ. 339, b3914.Google Scholar
Schwedt, T.J., Demaerschalk, B.M., Dodick, D.W., 2008. Patent foramen ovale and migraine: A quantitative systematic review. Cephalalgia. 28, 531–40.Google Scholar
Shuper, A., et al., 1995. ‘Complicated migraine-like episodes’ in children following cranial irradiation and chemotherapy. Neurology. 45, 1837–40.Google Scholar
Spalice, A., et al., 2016. Stroke and migraine is there a possible comorbidity? Ital J Pediatr. 42, 41.Google Scholar
Spector, J.T., et al., 2010. Migraine headache and ischemic stroke risk: An updated meta-analysis. Am J Med. 123, 612–24.Google Scholar
Stovner, L., et al., 2007. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 27, 193–210.Google Scholar
Swartz, R.H., Kern, R.Z., 2004. Migraine is associated with magnetic resonance imaging white matter abnormalities: A meta-analysis. Arch Neurol. 61, 1366–8.Google Scholar
Takano, T., et al., 2007. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci. 10, 754–62.Google Scholar
Tana, C., et al., 2013. New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: Is gold all that glitters? J Headache Pain. 14, 9.Google Scholar
Tfelt-Hansen, P., et al., 2000. Ergotamine in the acute treatment of migraine: A review and European consensus. Brain. 123, 9–18.Google Scholar
Tietjen, G.E., 2009. Migraine as a systemic vasculopathy. Cephalalgia. 29, 987–96.Google Scholar
Vahedi, K., et al., 2004. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol. 61, 1237–40.Google Scholar
Vijayan, N., Peacock, J.H., 2000. Spinal cord infarction during use of zolmitriptan: A case report. Headache. 40, 57–60.Google Scholar
Wammes-van der Heijden, E.A., et al., 2006. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology. 67, 1128–34.Google Scholar
Wolf, M.E., et al., 2011. Clinical and MRI characteristics of acute migrainous infarction. Neurology. 76, 1911–7.Google Scholar
Wooltorton, E., 2003. Risk of stroke, gangrene from ergot drug interactions. CMAJ. 168, 1015.Google Scholar
Yuzawa, I., et al., 2012. Cortical spreading depression impairs oxygen delivery and metabolism in mice. J Cereb Blood Flow Metab. 32, 376–86.Google Scholar
Zhang, J.H., et al., 2004. Genetic predisposition to neurological symptoms in lacunar infarction. Cerebrovasc Dis. 17, 273–9.Google Scholar

References

Baehring, J. M., Henchcliffe, C., Ledezma, C. J., Fulbright, R., and Hochberg, F. H. 2005. Intravascular lymphoma: Magnetic resonance imaging correlates of disease dynamics within the central nervous system. J Neurol Neurosurg Psychiatry, 76, 540–4.Google Scholar
Freedman, A.S., Aster, J.C., Böer-Auer, A. 2015. Intravascular Large Cell Lymphoma. In, Larson, R. A., Zic, J. A., Connor, R. F. (ed.), Waltham, MA.Google Scholar
Herrlinger, U., Brugger, W., Bamberg, M., et al. 2000. PCV salvage chemotherapy for recurrent primary CNS lymphoma. Neurology, 54, 1707–8.Google Scholar
Levin, K. H. and Lutz, G. 1996. Angiotropic large-cell lymphoma with peripheral nerve and skeletal muscle involvement: Early diagnosis and treatment. Neurology, 47, 1009–11.Google Scholar
Matsue, K., Hayama, B. Y., Iwama, K.-I., et al. 2011. High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma. Cancer, 117, 4512–21.Google Scholar
Nakamura, S., Ponzoni, M., and Campo, E. 2008. Intravascular large B-cell lymphoma, in Swerdlow, S. H, Campo, E., Harris, N. L., et al. (eds.): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Lyon: IARC Press, pp. 252–3.Google Scholar
Pfelger, J. and Tappeiner, J. 1959. Zur Kenntnis der systematisierten Endotheliomatose der cutanen Blutgefässe (Reticuloendotheliose). Haurarzt, 10, 359–63.Google Scholar
Ponzoni, M., Arrigoni, G., Gould, V. E., et al. 2003. Lack of CD29 (beta1 integrin) and CD54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol, 31, 220–226.Google Scholar
Ponzoni, M., Ferreri, A. J., Campo, E., et al. 2007. Definition, diagnosis, and management of intravascular large B-cell lymphoma: Proposals and perspectives from an international consensus meeting. J Clin Oncol, 25, 3168–73.Google Scholar
Rubens, E. O. 2008. Intravascular lymphoma. In Caplan, L. R. (ed.), Uncommon Causes of Stroke, 2nd edn. Cambridge: Cambridge University Press, pp. 533–7.Google Scholar
Sengupta, S., Pedersen, N. P., Davis, J. E., et al. 2011. Illusion of stroke: Intravascular lymphomatosis. Rev Neurol Dis, 8, e107–13.Google Scholar
Shimada, K., Matsue, K., Yamamoto, K. et al. 2008. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the ILCL study group in Japan. J Clin Oncol, 26, 3189–95.Google Scholar
Viali, S., Hutchinson, D. O., Hawkins, T. E., et al. 2000. Presentation of intravascular lymphomatosis as lumbosacral polyradiculopathy. Muscle Nerve, 23, 1295–300.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×